FDA Approves First Drug for Postpartum Depression, but Could Cost Up to $34,000

The Food and Drug Administration approved brexanolone, an intravenous medication specifically designed to treat postpartum depression that is expected to be sold under the brand name Zulresso in June, for a hefty price tag of about $34,000. The drug works quickly, with effects taking place within 48 hours. However, the medication itself is delivered by […]